Vitara Biomedical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $50M

  • Investors
  • 11

Vitara Biomedical General Information

Description

Developer of a therapeutic platform intended to support premature infants. The company offers natural physiological processes and a fluid-filled environment that mimics natural fetal conditions, and biologically inspired protective care to protect extremely premature newborns during their early growth outside the womb, enabling neonatal clinicians and families to improve the chances of survival and reduce long-term health complications for the fragile infants.

Contact Information

Website
www.vitara.com
Formerly Known As
Extend Device
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2301 Chestnut Street
  • 4th Floor
  • Philadelphia, PA 19103
  • United States
+1 (267)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 2301 Chestnut Street
  • 4th Floor
  • Philadelphia, PA 19103
  • United States
+1 (267)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitara Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 19-Nov-2024 $50M Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 02-Aug-2022 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 25-Feb-2021 $60M $60M Completed Startup
To view Vitara Biomedical’s complete valuation and funding history, request access »

Vitara Biomedical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Vitara Biomedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vitara Biomedical Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

Vitara Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026011087-A1 Oxygenator swap valves and method of using the same Pending 02-Jul-2024
US-20250177627-A1 Method and device for measuring oxygen saturation Pending 05-Dec-2023
AU-2024226929-A1 Cannula system including variable shape tip Pending 20-Feb-2023
EP-4669381-A1 Cannula system including variable shape tip Pending 20-Feb-2023
US-20260053998-A1 Cannula system including variable shape tip Pending 20-Feb-2023 A61M1/3666
To view Vitara Biomedical’s complete patent history, request access »

Vitara Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitara Biomedical Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
First Spark Ventures Venture Capital Minority
Flerie Venture Capital Minority
Fry's Path Capital Venture Capital Minority
GV Corporate Venture Capital Minority
ICLUB Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Vitara Biomedical FAQs

  • When was Vitara Biomedical founded?

    Vitara Biomedical was founded in 2019.

  • Where is Vitara Biomedical headquartered?

    Vitara Biomedical is headquartered in Philadelphia, PA.

  • What is the size of Vitara Biomedical?

    Vitara Biomedical has 44 total employees.

  • What industry is Vitara Biomedical in?

    Vitara Biomedical’s primary industry is Therapeutic Devices.

  • Is Vitara Biomedical a private or public company?

    Vitara Biomedical is a Private company.

  • What is Vitara Biomedical’s current revenue?

    The current revenue for Vitara Biomedical is .

  • How much funding has Vitara Biomedical raised over time?

    Vitara Biomedical has raised $150M.

  • Who are Vitara Biomedical’s investors?

    First Spark Ventures, Flerie, Fry's Path Capital, GV, and ICLUB are 5 of 11 investors who have invested in Vitara Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process